×
Grifols, S.A - 14 Year Stock Split History | GRFS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Stock Price History
Stock Splits
Market Cap
The most recent stock split for Grifols, S.A (GRFS) was a
2:1 split
on January 4, 2016. The combined total of all historical stock splits for Grifols, S.A result in
2.42 current shares
for every original share available at the IPO in 2011.
View More
Grifols, S.A - 14 Year Stock Split History | GRFS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Stock Price History
Stock Splits
Market Cap
Related Stocks
Company Name
Market
Cap
Chugai Pharmaceutical (CHGCY)
$79.9B
Zoetis (ZTS)
$70.1B
Daiichi Sankyo, - (DSNKY)
$43.9B
Takeda Pharmaceutical (TAK)
$43.7B
Sandoz Group AG (SDZNY)
$20.6B
Merck (MKKGY)
$18.3B
Astellas Pharma (ALPMY)
$17.4B
United Therapeutics (UTHR)
$17B
Summit Therapeutics (SMMT)
$15.9B
Shionogi (SGIOY)
$12.3B
Neurocrine Biosciences (NBIX)
$11.4B
Corcept Therapeutics (CORT)
$7.7B
Madrigal Pharmaceuticals (MDGL)
$7.5B
Orion OYJ (ORINY)
$7.4B
Hikma Pharmaceuticals Plc (HKMPF)
$6.2B
Stevanato Group S.p.A (STVN)
$6.2B
Ionis Pharmaceuticals (IONS)
$5B
Ono Pharmaceutical (OPHLF)
$4.7B
Recursion Pharmaceuticals (RXRX)
$4.2B
Crinetics Pharmaceuticals (CRNX)
$3.4B
Catalyst Pharmaceuticals (CPRX)
$2.7B
AMNEAL PHARMACEUTICALS, INC (AMRX)
$2.4B
Hypermarcas (HYPMY)
$2.2B
Centessa Pharmaceuticals (CNTA)
$2.1B
Soleno Therapeutics (SLNO)
$2B
BioCryst Pharmaceuticals (BCRX)
$1.9B
NewAmsterdam Pharma (NAMS)
$1.8B
Evotec AG (EVO)
$1.6B
Ardelyx (ARDX)
$1.5B
Indivior (INDV)
$1.5B